Literature DB >> 5644307

Placental transfer of cephalothin.

M A MacAulay, D Charles.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5644307     DOI: 10.1016/s0002-9378(15)33753-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  9 in total

1.  Maternal-fetal pharmacology of cefatrizine in the first 20 weeks of pregnancy.

Authors:  B Bernard; P Thielen; J Garcia-Cázares; C A Ballard
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

Review 2.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

3.  Transfer of a new cephalosporin antibiotic to the foetus and the amniotic fluid during a continuous infusion (steady state) and single repeated intravenous injections to the mother.

Authors:  H A Hirsch; S Herbst; R Lang; L Dettli; A Gablinger
Journal:  Arch Gynakol       Date:  1974-01-04

Review 4.  Pharmacokinetic properties of the cephalosporins.

Authors:  T Bergan
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Cephalosporins in urinary tract infection.

Authors:  L O Gentry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Pharmacological studies with lincomycin in late pregnancy.

Authors:  N M Duignan; J Andrews; J D Williams
Journal:  Br Med J       Date:  1973-07-14

Review 7.  Pharmacokinetics of antibiotics in pregnancy and labour.

Authors:  A Philipson
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

8.  Metabolic fate of SCE-129, a new antipseudomonal cephalosporin, after parenteral administration in rats and dogs.

Authors:  S Tanayama; K Yoshida; Y Kanai
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

Review 9.  Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules.

Authors:  A Heikkilä; R Erkkola
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.